PedAM
Pediatric Disease Annotations & Medicines
| Disease | n syndrome |
| Phenotype | C0023418|leukaemia |
| Sentences | 11 |
| PubMedID- 23907429 | (madan et al, 2006; weijerman et al, 2011).aryan and rezaei (2013b) do not understand our case–control study (down syndrome children with and without leukaemia). |
| PubMedID- 20064153 | Blasts in transient leukaemia in neonates with down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of gata1. |
| PubMedID- 23594030 | Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with down syndrome. |
| PubMedID- 21470198 | Reduced dose chemotherapy for acute promyelocytic leukaemia with adult down syndrome. |
| PubMedID- 24853125 | This case report is followed by a concise review of the literature discussing the different entities and pathomechanisms of tmd and acute megakaryocytic leukaemia in patients with or without down syndrome. |
| PubMedID- 21933171 | Acute lymphoblastic leukaemia in children with down syndrome: an updated review. |
| PubMedID- 23695017 | Allergy and acute leukaemia in children with down syndrome: a population study. |
| PubMedID- 25155832 | Haematopoietic development and leukaemia in down syndrome. |
| PubMedID- 24803665 | For example, tartaglia and colleagues assessed ptpn11 (shp2) mutations by comparing somatic mutations in juvenile myelomonocytic leukaemia (jmml) with noonan syndrome germline mutations, and they identified a greater activation of the ras/mapk activation for the jmml‐associated mutations (tartaglia et al, 2003). |
| PubMedID- 20405513 | Myeloid leukaemia in children with down syndrome: report of the registry-based french experience between 1990 and 2003. |
| PubMedID- 23907432 | Comment on ‘allergy and acute leukaemia in children with down syndrome: a population study. |
Page: 1